相关实验视频

Updated: May 20, 2025

Generation of Multivirus-specific T Cells to Prevent/treat Viral Infections after Allogeneic Hematopoietic Stem Cell Transplant

Generation of Multivirus-specific T Cells to Prevent/treat Viral Infections after Allogeneic Hematopoietic Stem Cell Transplant

Published on: May 27, 2011

在异构血型干细胞移植后的多种病毒

Maria Alejandra Mendoza¹, Hannah Imlay¹

¹Division of Infectious Diseases, Department of Internal Medicine, University of Utah, Salt Lake City, UT 84112, USA.

|March 27, 2025

概括

多种病毒 (PyVs) 在干细胞移植患者中引起严重疾病. 目前的治疗方法有限,这凸显了对BK多样性瘤病毒 (BKPyV) 和JC多样性瘤病毒 (JCPyV) 感染的更好的诊断和治疗的需要.

科学领域:

病毒学病毒学
免疫学免疫学免疫学
在瘤学瘤学.

背景情况:

多种类型病毒 (PyVs),包括BK多种类型病毒 (BKPyV) 和JC多种类型病毒 (JCPyV),是全原造血干细胞移植 (allo-HSCT) 接受者的重大致病原因.
在免疫抑制下病毒的重新激活会导致诸如BKPyV相关的出血性囊炎 (HC) 和JCPyV相关的渐进式多焦点白内障 (PML) 等疾病.

研究的目的:

本综述综合了PyV病毒学,临床表现和管理挑战的当前知识.
它强调了对诊断工具和治疗策略的进步的关键需求,以改善这种患者群体的治疗结果.

主要方法:

文献综述,重点关注多病毒感染后合金-HSCT.
对临床表现,诊断方法和治疗结果的分析.

主要成果:

BKPyV通常会导致出血性囊炎,而JCPyV会导致渐进的多焦点白内障.
诊断依赖于核酸放大测试和临床评估.
缺乏有效的抗病毒治疗方法,管理主要是支持性.

结论:

聚瘤病毒感染对alo-HSCT接受者构成重大威胁,需要提高诊断准确性和新的治疗干预措施.
进一步的研究对于开发有效的治疗方法和减轻与这些病毒感染相关的发病率和死亡率至关重要.

关键词:

这就是BK病毒.这就是JC病毒.血液造血干细胞移植的结果是什么?出血性囊炎的发生这种病毒是多聚马病毒.渐进的多焦点白细胞脑病变.

更多相关视频

Development of an IFN-γ ELISpot Assay to Assess Varicella-Zoster Virus-specific Cell-mediated Immunity Following Umbilical Cord Blood Transplantation

Development of an IFN-γ ELISpot Assay to Assess Varicella-Zoster Virus-specific Cell-mediated Immunity Following Umbilical Cord Blood Transplantation

Published on: July 9, 2014

Expanding Cytotoxic T Lymphocytes from Umbilical Cord Blood that Target Cytomegalovirus, Epstein-Barr Virus, and Adenovirus

Expanding Cytotoxic T Lymphocytes from Umbilical Cord Blood that Target Cytomegalovirus, Epstein-Barr Virus, and Adenovirus

Published on: May 7, 2012

相关概念视频

Bone Marrow Sampling and Transplants

Bone Marrow Sampling and Transplants

Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...

Regulation of Hematopoietic Stem Cells

Regulation of Hematopoietic Stem Cells

All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...

Stem Cell Therapy for Tissue Regeneration

Stem Cell Therapy for Tissue Regeneration

Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell...